Information  X 
Enter a valid email address

Pets at Home Grp (PETS)

  Print      Mail a friend

Wednesday 05 August, 2020

Pets at Home Grp

Director/PDMR Shareholding

RNS Number : 2778V
Pets At Home Group Plc
05 August 2020
 

5 August 2020

Pets at Home Group plc

Director/PDMR Shareholding

 

 

1.

Details of the person discharging managerial responsibilities/person closely associated

(a)

Name

Mike Iddon

2.

Reason for the notification

(a)

Position/status

PDMR and CFO

(b)

Initial notification/ Amendment

Initial notification

3.

Details of the issuer

(a)

Name

Pets at Home Group Plc

(b)

LEI

N/A

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

(a)

Description of the Financial Instrument

Ordinary shares of 1 pence each in Pets at Home Group Plc

 

(b)

Identification code of the Financial Instrument

ISIN  GB00BJ62K685

(c)

Nature of the transaction

Mike Iddon has exercised his 2017 Restricted Stock Plan through a Sell To Cover transaction, acquiring 82,154 shares, selling 39,524 of these shares to cover the costs associated with acquisition.

(d)

Price(s) and volume(s)

Price(s)

Volume(s)



£3.08 per share

82,154  shares

(e)

Aggregated information

-  Aggregated volume

-   Price

Price

Aggregated Volume

Aggregate Total

£3.08 per share

 

£3.08 per share

82,154 shares acquired

39,524 shares sold

£253,006.60

 

£121,733.92

(f)

Date of the transaction

31 July 2020

(g)

Place of the transaction

London Stock Exchange (XLON)

 

Enquiries :

 

Lucy Williams

Group Legal Director and Company Secretary

Pets at Home Group plc

Tel: 0161 486 6688


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
DSHKKPBQPBKDKFK

a d v e r t i s e m e n t